Sunday, February 17, 2013

Johnson Johnson takes up residence 3rd Risperdal Lawsuit for

If solutions are people, My associate, Like Mitt Romney famously detailed in Iowa in August 2011, Then we feeling a little bad for our fellow person called Janssen medication, A division of health giant Johnson Johnson.

They just got dinged with a $158 million settlement in a Medicaid fraud case in Texas for false or misleading statements about the security, Cost and helpfulness of the expensive anti-Psychotic remedies Risperdal, And improperly affecting officials and doctors to push the drug. We won feel too waywardly, Because Janssen got off easy keeping this one. They don have to admit to any liability with the payment, And Johnson Johnson who made billions away from the sale of Risperdal will barely blink their corporate eyeballs as they make out the check.

This is the third state settlement for Johnson Johnson in link to their promotion and marketing of Risperdal, An atypical antipsychotic medication that was touted to be a drug better than sliced bread and with far less results. (Too bad companies don eat, amigo.) They been ordered to pay $327 million in sc, And $258 million in Louisiana in similar state legal actions.

That brings the grand total to $743 million the company covers allegedly fraudulently marketing the drug Risperdal. Janssen for few Freudian psychoanalysis.

Nothing incorrect? Then why have two states already found you guilty of doing activities you thought about and why are you so willing to pay out three-Groups of a billion dollars so far, Innocent parties rarely would be willing to pay out such enormous sums of money unless they knew there was something more to dollars,

Essential check out the interview Pharmalot has just published with Allen Jones, The whistleblower the Free Advertising! Drive Massive Free Traffic To Your Site Or Affiliate Links. Use A Method So New, So Secret No One Else Uses, To Get Free Traffic From Classified Ads. No More Wasting Money On PPC Or Being Banned By Craigslist! **avg $ /sale Now .50! C.l.a.s.s. – Classified Listings Advertising Secret Sources! Free Ads! actual Risperdal cases (Without his taking a stand for what right and ethical, The states would never had a case to make). It sad to see the results is a much more cynical man:

Pharmalot: Whoever else learned from all this?

Jones: I live in a world that seems unique to me than the one I stumbled into since this began. There were so many layers of disillusionment after seeing what I thought were said to be good intentions of the pharmaceutical industry and government. I see greed and cynicism and bureaucrats securing their fat bellies and fat pensions. But I've acquired more skills to reside a cynical world in which I see I live in. I lost of a heck of a lot of innocence in the act.

But maybe that the inevitable result of pharmaceutical companies who put profit ahead of all else even ethical marketing of some.

Hence my continued skepticism about any new psychiatric medication to to enter the world. Over the last decade, We seen virtually all the psychiatric pharmaceutical companies be indicted or pay settlements or fines for their unethical behavior concerning marketing and selling such medications.

We can only hope these settlements make them think twice for behaving badly in the future. But when you are shareholder profits versus a possible future fine and a slap on the wrist, My gut tells me to trust companies will continue to pursue shareholder profits at all expenses Even when what it appears they certainly is illegal and unethical, And appears to cause very real health complications to a myriad of people.

Read the full appointment with Allen Jones at Pharmalot: Risperdal Whistleblower: J Credo is almost certainly 'Empty Words'

Read the news story on the understanding: Johnson Johnson forms Texas lawsuit for $158M

Doctor. John Grohol is the CEO and head honcho of Psych Central. Medical professional. Grohol sits on the article board of the journal Cyberpsychology, Behavior and Social Networking and is a founding board member and treasurer of the Society for Participatory prescription drugs